Status:
RECRUITING
Association of a Digital Signature of Physical Activity and Sedentary Lifestyle With the Development of Multimorbidities in Chronic Diseases (eMOB)
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Exercise
Sedentary Behavior
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Physical activity (PA) and sedentary lifestyle are determinants in the development of chronic diseases and associated quality of life alterations. PA levels are correlated with quality of life and mor...
Detailed Description
Study design : eMOB study is a monocentric prospective cohort study. We aim to explore in a longitudinal study the association of a digital signature of PA and sedentary lifestyle with the developmen...
Eligibility Criteria
Inclusion Criteria:
-
Patient follow-up at CHU Clermont-Ferrand for a chronic disease in one of the following observational cohorts:
- Inflammatory rheumatic disease(rheumatoid arthritis, spondyloarthritis) included in the RCVRIC cohort (CPP Sud-Est VI N° ID-RCB- A01847-40)
- Pre-surgical knee and hip osteoarthritis (Evalmob) (ID-RCB N° 2019- A01017-50)
- Major depressive disorder included in the FACE-DR cohort (CNIL agreement: DR- 2015-673) and Bipolar disorder included in the FACE-BD cohort (CPP Ile de France IX; January 18, 2010) of the Adult Psychiatry Department B
- Type 2 diabetes included in the cohort of the sport medicine service "Rehabilitation T2" (CNIL agreement 0164)
- Obesity included in the "Obesity" sports medicine service cohort (CNIL agreement 0164)
- COPD included in the "COPD Rehabilitation" sports medicine service cohort (CNIL agreement 0164)
- Chronic pain cohort (eDOL) (CPP West II N° ID-RCB 2020-A02027-32)
-
Affiliation to a social security system.
-
Able to provide written informed consent to participate in the research.
Exclusion Criteria:
- Inability to practice physical activity
- Pregnant or breastfeeding
- Refusal to participate
- Minors or adults under the protection of the law or under the protection of justice.
Key Trial Info
Start Date :
December 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT05578495
Start Date
December 7 2023
End Date
December 1 2030
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000